AAAAAA

   
Results: 1-9 |
Results: 9
PHARMACODYNAMIC ACTIVITY AND ANTITHROMBOTIC EFFICACY OF RPR120844, A NOVEL INHIBITOR OF COAGULATION-FACTOR XA
Authors: MORGAN S BENTLEY R BOSTWICK J KASIEWSKI C CHU V BROWN K EWING WR PAULS H SPADA A PERRONE M DUNWIDDIE C LEADLEY R
Citation: S. Morgan et al., PHARMACODYNAMIC ACTIVITY AND ANTITHROMBOTIC EFFICACY OF RPR120844, A NOVEL INHIBITOR OF COAGULATION-FACTOR XA, The FASEB journal, 12(5), 1998, pp. 5531-5531
EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARIN IN COMBINATION WITH A PLATELET FIBRINOGEN RECEPTOR ANTAGONIST IN A CANINE MODEL OF UNSTABLE ANGINA
Authors: LEADLEY R KASIEWSKI C BOSTWICK J BENTLEY R KLEIN S PERRONE M DUNWIDDIE C
Citation: R. Leadley et al., EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARIN IN COMBINATION WITH A PLATELET FIBRINOGEN RECEPTOR ANTAGONIST IN A CANINE MODEL OF UNSTABLE ANGINA, Circulation, 98(17), 1998, pp. 4194-4194
INHIBITION OF VENOUS THROMBUS FORMATION IN THE RABBIT BY ANTITHROMBOTIC AGENTS WITH DIFFERENT MECHANISMS OF ACTION
Authors: BOSTWICK J BENTLEY R DUNWIDDIE C LEADLEY R
Citation: J. Bostwick et al., INHIBITION OF VENOUS THROMBUS FORMATION IN THE RABBIT BY ANTITHROMBOTIC AGENTS WITH DIFFERENT MECHANISMS OF ACTION, The FASEB journal, 11(3), 1997, pp. 1817-1817
INHIBITION OF REPETITIVE THROMBUS FORMATION IN THE STENOSED CANINE CORONARY-ARTERY BY ENOXAPARIN, BUT NOT BY UNFRACTIONATED HEPARIN
Authors: KASIEWSKI C BOSTWICK J BENTLEY R DUNWIDDIE C PERRONE M LEADLEY R
Citation: C. Kasiewski et al., INHIBITION OF REPETITIVE THROMBUS FORMATION IN THE STENOSED CANINE CORONARY-ARTERY BY ENOXAPARIN, BUT NOT BY UNFRACTIONATED HEPARIN, The FASEB journal, 11(3), 1997, pp. 1818-1818
IN-VITRO CHARACTERIZATION OF A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST RPR-109891 AND ITS ACTIVE METABOLITE RPR-109039
Authors: CHU V SABATINO R BROWN K KLEIN S CZEKAJ M GARDNER C LEADLEY R BOSTWICK J KASIEWSKI C OCONNOR E PERRONE M DUNWIDDIE C
Citation: V. Chu et al., IN-VITRO CHARACTERIZATION OF A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST RPR-109891 AND ITS ACTIVE METABOLITE RPR-109039, Blood, 90(10), 1997, pp. 3214-3214
ANTITHROMBOTIC EFFECT OF RPR110173 IN A CANINE MODEL OF REPETITIVE THROMBUS FORMATION
Authors: BOSTWICK J KASIEWSKI C KLEIN S DUNWIDDIE C LEADLEY R
Citation: J. Bostwick et al., ANTITHROMBOTIC EFFECT OF RPR110173 IN A CANINE MODEL OF REPETITIVE THROMBUS FORMATION, The FASEB journal, 10(3), 1996, pp. 238-238
COMPARISON OF ENOXAPARIN, HIRULOG, AND HEPARIN AS ADJUNCTIVE ANTITHROMBOTIC THERAPY DURING THROMBOLYSIS WITH RTPA IN THE STENOSED CANINE CORONARY-ARTERY
Authors: KASIEWSKI C BOSTWICK J BENTLEY R MCVEY M WHITE F PERRONE M DUNWIDDIE C LEADLEY R
Citation: C. Kasiewski et al., COMPARISON OF ENOXAPARIN, HIRULOG, AND HEPARIN AS ADJUNCTIVE ANTITHROMBOTIC THERAPY DURING THROMBOLYSIS WITH RTPA IN THE STENOSED CANINE CORONARY-ARTERY, The FASEB journal, 10(3), 1996, pp. 239-239
ANGIOGRAPHIC AND HISTOLOGIC RESTENOSIS FOLLOWING ANGIOPLASTY IN THE SWINE CORONARY-ARTERY IS INHIBITED BY AN ORALLY-ACTIVE PDGF-RECEPTOR TYROSINE KINASE INHIBITOR, RPR 101511A
Authors: BILDER GE WENTZ T LEADLEY R AMIN D DUGAN L OCONNOR B NEEDLE S HYERS M SPADA A PAGE K PERRONE M DUNWIDDIE C
Citation: Ge. Bilder et al., ANGIOGRAPHIC AND HISTOLOGIC RESTENOSIS FOLLOWING ANGIOPLASTY IN THE SWINE CORONARY-ARTERY IS INHIBITED BY AN ORALLY-ACTIVE PDGF-RECEPTOR TYROSINE KINASE INHIBITOR, RPR 101511A, Circulation, 94(8), 1996, pp. 2719-2719
IN-VIVO ANTITHROMBOTIC ACTIVITY OF RG13965, A NOVEL PLATELET FIBRINOGEN RECEPTOR ANTAGONIST
Authors: BOSTWICK J KASIEWSKI C CHU V SABATINO R KLEIN S CZEKAJ M GARDNER C PERRONE M DUNWIDDIE C COOK J LEADLEY R
Citation: J. Bostwick et al., IN-VIVO ANTITHROMBOTIC ACTIVITY OF RG13965, A NOVEL PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, The FASEB journal, 9(4), 1995, pp. 938-938
Risultati: 1-9 |